Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) price on Wednesday, February 05, remained unchanged to $2.02.
A look at the stock’s price movement, the close in the last trading session was $2.02, moving within a range at $1.94 and $2.09. The beta value (5-Year monthly) was -0.055. Turning to its 52-week performance, $4.83 and $0.60 were the 52-week high and 52-week low respectively. Overall, RVPH moved 6.32% over the past month.
Reviva Pharmaceuticals Holdings Inc’s market cap currently stands at around $94.09 million, with investors looking forward to this quarter’s earnings report slated for in March.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RVPH is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 75% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend RVPH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RVPH’s current price about 7.79% and 13.98% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 57.61, while 7-day volatility ratio is 7.78% and 11.55% in the 30-day chart. Further, Reviva Pharmaceuticals Holdings Inc (RVPH) has a beta value of -0.15, and an average true range (ATR) of 0.22.
If we refocus on Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH), historical trading data shows that trading volumes averaged 1.33 over the past 10 days and 2.86 million over the past 3 months. The company’s latest data on shares outstanding shows there are 46.58 million shares.
The 10.62% of Reviva Pharmaceuticals Holdings Inc’s shares are in the hands of company insiders while institutional holders own 28.91% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.3 million on 2024-10-31, giving us a short ratio of 19.04. The data shows that as of 2024-10-31 short interest in Reviva Pharmaceuticals Holdings Inc (RVPH) stood at 1859.0 of shares outstanding, with shares short falling to 5.47 million registered in 2024-09-30. Current price change has pushed the stock 11.60% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RVPH stock continues to rise going into the next quarter.
